Table 1.
Basic and clinical characteristics of the patients in present study (n = 50)
| Characteristics | Number of patients (%) |
|---|---|
|
Age (years) |
|
| Median (range) |
54 (39–64) |
|
Gender |
|
| Male/Female |
42 (84.0)/8 (16.0) |
|
ECOGaperformance status |
|
| 0-1 |
47 (94.0) |
| 2 |
3 (6.0) |
|
Pathology |
|
| Squamous-cell carcinoma (SCC) |
50 (100.0) |
|
Tumorstagebafter surgery |
|
| I-II |
17 (34.0) |
| III-IV |
33 (66.0) |
|
Time form surgery to recurrences (months) |
|
| Median (range) |
13.0 (5.0-32.0) |
|
Sites of recurrencec |
|
| Anastomotic |
7 (14.0) |
| Supraclavicular lymph nodes |
18 (36.0) |
| Mediastinal lymph nodes |
15 (30.0) |
| Abdominal lymph nodes |
5 (10.0) |
| Supraclavicular/mediastinal lymph nodes |
4 (8.0) |
| Supraclavicular/abdominal lymph nodes | 1 (2.0) |
a: Eastern Cooperative Oncology Group; b: Staging system, 6th edition, American Joint Committee on Cancer, 2002; c: 4 patients with supraclavicular and mediastinal lymph nodes recurrence, 1 patients with mediastinal and abdominal lymph nodes recurrence.